Donald Trump announced phased tariffs on imported generic medicines starting August 2026. These tariffs will gradually increase to 200 percent over three years. This policy aims to reshore pharmaceutical production back into America. India, a major supplier of affordable generics, faces significant impact from these changes. The move adds uncertainty to ongoing bilateral trade agreement.
Related Posts
Sreeshankar eyes golden leap at CWG 2026: ‘Hopefully change the colour of medal’
Murali Sreeshankar is preparing for upcoming athletic events after a serious injury. He aims to improve upon his previous silver…
Throat slit, dying woman writes ‘husband is my killer’ in chilling death note
A woman named her husband as her killer in a dying message. She was found with her throat slit outside…
Watch: Kheer spills on Kerala minister during launch of free bus rides for women
During the launch of Kerala’s free bus travel scheme for women, Minister Bindu Krishna had payasam spill on her inside…